{
    "2020-11-04": [
        [
            {
                "time": "",
                "original_text": "康龙化成(03759.HK)：实际控制人及其一致行动人质押190万股及解押220.92万股A股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "实际控制人",
                        "一致行动人",
                        "质押",
                        "解押"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "浦银国际：康龙化成重申买入评级 目标价升至135港元",
                "features": {
                    "keywords": [
                        "浦银国际",
                        "康龙化成",
                        "买入评级",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(03759)获一致行动人解除质押220.92万股A股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "一致行动人",
                        "解除质押"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "浦银国际：重申“买入”康龙化成(03759) 升目标价至135港元",
                "features": {
                    "keywords": [
                        "浦银国际",
                        "买入",
                        "康龙化成",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759.SZ)实际控制人之一楼小强及其一致行动人合计质押190万股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "实际控制人",
                        "楼小强",
                        "一致行动人",
                        "质押"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药恢复高增长，未来跟随政策变化选股——兴证医药2020年11月投资月报",
                "features": {
                    "keywords": [
                        "医药",
                        "高增长",
                        "政策变化",
                        "选股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中泰证券：疫情加速全球创新药产业链转移 预计全年将持续高景气（附股）",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "疫情",
                        "创新药",
                        "产业链转移",
                        "高景气"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}